Log in to save to my catalogue

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_02126484v1

Publication information

Publisher

United States: The American Association for the Advancement of Science

More information

Scope and Contents

Contents

Immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis induce sustained clinical responses in a sizable minority of cancer patients. We found that primary resistance to ICIs can be attributed to abnormal gut microbiome composition. Antibiotics inhibited the clinical benefit of ICIs in patients with advanced cancer. Fecal microbiota trans...

Alternative Titles

Full title

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_02126484v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_02126484v1

Other Identifiers

ISSN

0036-8075

E-ISSN

1095-9203

DOI

10.1126/science.aan3706

How to access this item